Multiple
News roundup Wednesday June 4
ASCO 2025: Flerie's portfolio company shows positive Phase II results
Bioteknik
Fleries and Toleranzia merger approved
The general meetings of Flerie and Toleranzia have approved the merger plan...
News roundup Wednesday, May 7
Curasight
News roundup Friday, May 2
Diamyd Medical
News round-up Monday, April 28
Magle PharmaCept
News roundup Wednesday April 16
BioArctic
News roundup Wednesday April 9
Takeda
News round-up Monday, April 7
Sartorius
News roundup Friday, April 4
Quia Pharma
News roundup Thursday, April 3
Faron Pharmaceuticals
News roundup Thursday, March 27
Odinwell
Notes
Hansa Biopharma appoints new CMO
Perpetua Medical sells assets for SEK 10 million
Lipum reaches 89 percent subscription of warrants
EQL Pharma expands to Germany and the Netherlands
Oncopeptides Pepaxti included in European treatment guidelines
NEWSLETTER
NEWS
In the shadow of the GLP-1 hype: new report criticizes pharmaceutical companies' patent strategies
Five Nordic biotech stock market winners in H1 2025
Chugai and Gero in billion-dollar deal within AI
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The EU's new life science strategy – a step in the right direction or just fluff?
Early signs of spring in an otherwise frosty biotech landscape
